The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

19 Sep 2012 07:00

RNS Number : 5733M
Standard Life Euro Pri Eqty Tst PLC
19 September 2012
 



 

Standard Life European Private Equity Trust PLC

 

Investment update for the quarter ended 30 June 2012

 

·; NAV fell by 1.3% to 232.1p for the quarter ended 30 June 2012

·; NAV total return was up 2.0% for the first nine months of the current financial year starting 1 October 2011

·; Realised gains and income during the quarter were £6.2million (1.6% of NAV). The unrealised loss on the portfolio on a constant exchange rate basis was £1.6 million (0.4% of NAV); in addition, there was an unrealised foreign exchange loss of £8.7 million (2.3% of NAV).

·; 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2012

·; Outstanding commitments were £136.0 million at 18 September 2012

·; Net cash was £8.5 million at 18 September 2012

 

For the quarter ended 30 June 2012 the Company's net asset value per ordinary share ("NAV") fell by 1.3% to 232.1p (diluted - 229.3p), from 235.2p (diluted - 232.3p) at 31 March 2012. At 30 June 2012 the Company's net assets were £377.0 million (31 March 2012 - £381.9 million).

 

New transactional activity remained subdued in the European private equity market in the second quarter of 2012, due to the impact of the difficult macro-economic and political environment in Europe and constraints on debt availability for leveraged transactions. A total of €13.7 billion of transactions by enterprise value was reported during the quarter, which was slightly higher than the first quarter of 2012, but compared to a value of €30.6 billion in the second quarter of 2011. Notwithstanding, the Manager continued to see exit activity across the Company's portfolio as private equity managers focused on selling investee companies, particularly to corporate buyers.

 

The closing value of the Company's portfolio of 37 private equity fund interests was £388.4 million at 30 June 2012 (31 March 2012 - £396.0 million). The total unrealised loss for the quarter ended 30 June 2012 was £10.3 million, of which £1.6 million was an unrealised loss on a constant exchange rate basis and £8.7 million was an unrealised foreign exchange loss. The £1.6 million fall in the value of the portfolio on a constant exchange rate basis reflected weaker listed equity markets, partially offset by positive earnings growth at many underlying portfolio companies. The FTSE All-Share Index and the MSCI Europe Index (in euros) fell by 3.7% and 4.6% respectively during the quarter. The unrealised foreign exchange loss was driven by the euro depreciating by 3.0% relative to sterling over the quarter.

 

During the period the Company funded £8.1 million of draw downs (six months ended 31 March 2012 - £16.1 million) and received £11.5 million of distributions (six months ended 31 March 2012 - £33.4 million). The distributions received generated £6.2 million of realised gains and income, which was equivalent to a return of 2.2 times the acquisition cost of the realised investments.

 

The Company had total outstanding commitments to its 37 private equity fund interests of £122.8 million at 30 June 2012 (31 March 2012 - £133.9 million).

 

At 30 June 2012 the Company had net indebtedness of £11.8 million (31 March 2012 - net indebtedness of £14.4 million).

 

During the period from 30 June 2012 to 18 September 2012 the Company funded £10.1 million of draw downs and received £31.1 million of distributions. On 4 September 2012 the Company made a new fund commitment, with a €30 million commitment to Equistone Partners Europe Fund IV. The Company has existing commitments to Equistone Partners Europe Funds I, II and III. Accordingly, at 18 September 2012 the Company's total outstanding commitments and net cash balance were £136.0 million and £8.5 million respectively.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2012 on or around 3 December 2012.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEVLFFLKFEBBV
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.